These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 7537948
21. [Perioperative multi-modality treatment strategies in esophageal cancer]. Porschen R. Z Gastroenterol; 1993 Nov; 31(11):680-5. PubMed ID: 8291282 [Abstract] [Full Text] [Related]
30. Combined modality therapy of esophageal cancer: changes in the standard of care? Shah MA, Kelsen DP. Ann Surg Oncol; 2004 Jul; 11(7):641-3. PubMed ID: 15197008 [No Abstract] [Full Text] [Related]
31. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Medgyesy CD, Wolff RA, Putnam JB, Ajani JA. Cancer; 2000 Jan 15; 88(2):262-7. PubMed ID: 10640955 [Abstract] [Full Text] [Related]
32. [Cancers of the esophagus. Combined modality therapy by radiotherapy, chemotherapy with or without surgery]. Calais G, Bedenne L. Bull Cancer Radiother; 1995 Jan 15; 82(2):137-46. PubMed ID: 7546884 [No Abstract] [Full Text] [Related]
34. [Analysis of cases of complete response (CR) in esophageal and gastric cancer]. Suzuki T, Okazumi S, Ochiai T. Gan To Kagaku Ryoho; 2000 Nov 15; 27(13):2059-65. PubMed ID: 11103237 [Abstract] [Full Text] [Related]
35. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer. Veuillez V, Rougier P, Seitz JF. Best Pract Res Clin Gastroenterol; 2007 Nov 15; 21(6):947-63. PubMed ID: 18070697 [Abstract] [Full Text] [Related]
36. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients? Yu E, Dar R, Rodrigues GB, Stitt L, Videtic GM, Truong P, Tomiak A, Ash R, Brecevic E, Inculet R, Malthaner R, Vincent M, Craig I, Kocha W, Lefcoe M. Radiother Oncol; 2004 Nov 15; 73(2):141-8. PubMed ID: 15542160 [Abstract] [Full Text] [Related]
37. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy. Motoyama S, Sugiyama T, Ueno Y, Okamoto H, Takasawa S, Nanjo H, Watanabe H, Maruyama K, Okuyama M, Ogawa J. Ann Surg Oncol; 2006 Dec 15; 13(12):1724-31. PubMed ID: 17009160 [Abstract] [Full Text] [Related]
38. [Preoperative radiochemotherapy in esophageal carcinoma]. Stahl M. Praxis (Bern 1994); 1996 Mar 05; 85(10):303-6. PubMed ID: 8628959 [Abstract] [Full Text] [Related]
39. Toxicity of chemotherapy for esophageal carcinoma. Ilson D. Chest Surg Clin N Am; 1997 Aug 05; 7(3):551-63; discussion 564. PubMed ID: 9246402 [Abstract] [Full Text] [Related]
40. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus. Yano M, Yasuda T, Miyata H, Fujiwara Y, Takiguchi S, Monden M. J Surg Oncol; 2005 Mar 15; 89(4):244-50; discussion 250. PubMed ID: 15726612 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]